Bio-Techne Corporation or Bausch Health Companies Inc.: Who Leads in Yearly Revenue?

Bio-Techne vs. Bausch Health: A Revenue Showdown

In the competitive landscape of biotechnology and pharmaceuticals, revenue growth is a key indicator of success. Over the past decade, Bausch Health Companies Inc. has consistently outperformed Bio-Techne Corporation in terms of yearly revenue. From 2014 to 2023, Bausch Health's revenue peaked in 2015, reaching approximately 10.5 billion, while Bio-Techne's highest revenue was around 1.14 billion in 2023. Despite Bausch Health's dominance, Bio-Techne has shown impressive growth, with its revenue increasing by over 200% from 2014 to 2023. This trend highlights Bio-Techne's potential to close the gap in the coming years. However, the data for 2024 is incomplete, leaving room for speculation on future performance. As the industry evolves, both companies are poised to leverage their strengths, with Bio-Techne focusing on innovation and Bausch Health capitalizing on its established market presence.